Wuhan, China

Quan Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Quan Liu. Retrieved from https://idiyas.com/inventor/quan-liu-ojlx5jrn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 28.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Quan Liu from Wuhan, China**

Introduction

Quan Liu is a prominent inventor based in Wuhan, China, known for his significant contributions to the field of biopharmaceuticals. His innovative work focuses on developing novel therapies that aim to improve human health and combat diseases. With a commitment to advancing medical science, Liu has successfully secured a patent that demonstrates his expertise and vision.

Latest Patents

Liu holds a patent for a series of BTK (Bruton's Tyrosine Kinase) inhibitors. This patent includes a compound along with its pharmaceutically acceptable salts, tautomer forms, or prodrugs represented by specific formulas (I), (II), (III), or (IV). These inhibitors are crucial in the development of targeted therapies for various diseases, showcasing Liu's innovative approach to pharmaceutical research.

Career Highlights

Currently, Quan Liu is associated with the Hubei Bio-pharmaceutical Industrial Technological Institute Inc., where he plays a vital role in research and development. His dedication to the field of biopharmaceuticals has positioned him as an influential figure within the industry, contributing to important advancements in treatment methodologies.

Collaborations

Liu collaborates with talented coworkers such as Xuehai Wang and Chengde Wu. Together, they work on various projects that push the boundaries of medical science and develop new solutions to health challenges. Their teamwork exemplifies the spirit of innovation and collaboration prevalent in research institutions that strive for excellence.

Conclusion

In conclusion, Quan Liu is an exemplary inventor whose work with BTK inhibitors presents promising potential in the pharmaceutical landscape. His collaboration with esteemed colleagues and his tenure at the Hubei Bio-pharmaceutical Industrial Technological Institute Inc. underscore his commitment to innovation. Liu's contributions are paving the way for improved therapeutic options that could benefit countless individuals in the fight against disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…